US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 1.780
  • +0.140+8.54%
Close Nov 21 16:00 ET
  • 1.870
  • +0.090+5.06%
Post 19:27 ET
79.32MMarket Cap-1171P/E (TTM)

Werewolf Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Werewolf Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 375.000K--
--2024/Q4-- / 301.590K--
--2024/Q30.000 / 709.320K--
--2024/Q21.143M / 841.780K--
--2024/Q1742.000K / 1.457M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 375.000K--
--2024/Q4-- / 301.590K--
--2024/Q30.000 / 709.320K--
--2024/Q21.143M / 841.780K--
--2024/Q1742.000K / 1.457M--

Unlock Free Earnings Estimates

Werewolf Therapeutics Earnings Reports

  • Werewolf Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 09:13 ET

  • Werewolf Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:14 ET

  • Werewolf Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 3 07:15 ET

  • Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

    May 3 07:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data